Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Clinical and Experimental Immunology
|
December 12, 2001
The effects of iron deficiency on lymphocyte cytokine production and activation: preservation of hepatic iron but not at all cost
J Jason, L K Archibald, O C Nwanyanwu, et al.
The Journal of Infectious Diseases
|
July 29, 2000
Natural T, gammadelta, and NK cells in mycobacterial, Salmonella, and human immunodeficiency virus infections
J Jason, I Buchanan, L K Archibald, et al.
Clinical Immunology (Orlando, Fla.)
|
July 24, 2001
Cytokines and malaria parasitemia
J Jason, L K Archibald, O C Nwanyanwu, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 22, 2011
Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists
Phillip M Cowley, James Baker, Kirsteen I Buchanan, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2010
The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonists
Phillip M Cowley, James Baker, David R Barn, et al.
Journal of Medicinal Chemistry
|
October 19, 2001
Alpha-amino acid phenolic ester derivatives: novel water-soluble general anesthetic agents which allosterically modulate GABA(A) receptors
A Anderson, D Belelli, D J Bennett, et al.
Journal of Medicinal Chemistry
|
January 4, 2021
Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action Studies
Candice Soares de Melo, Vinayak Singh, Alissa Myrick, et al.
Journal of Medicinal Chemistry
|
August 1, 2025
Design and Development of Lysyl tRNA Synthetase Inhibitors, for the Treatment of Tuberculosis
Susan H Davis, Michael Mathieson, Kirsteen I Buchanan, et al.
Nature Communications
|
October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Simon R Green, Susan H Davis, Sebastian Damerow, et al.
ACS Infectious Diseases
|
October 6, 2016
Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis
Yumi Park, Angela Pacitto, Tracy Bayliss, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Clinical and Experimental Immunology
|
December 12, 2001
The effects of iron deficiency on lymphocyte cytokine production and activation: preservation of hepatic iron but not at all cost
J Jason, L K Archibald, O C Nwanyanwu, et al.
The Journal of Infectious Diseases
|
July 29, 2000
Natural T, gammadelta, and NK cells in mycobacterial, Salmonella, and human immunodeficiency virus infections
J Jason, I Buchanan, L K Archibald, et al.
Clinical Immunology (Orlando, Fla.)
|
July 24, 2001
Cytokines and malaria parasitemia
J Jason, L K Archibald, O C Nwanyanwu, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 22, 2011
Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists
Phillip M Cowley, James Baker, Kirsteen I Buchanan, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 16, 2010
The discovery of novel indole-2-carboxamides as cannabinoid CB(1) receptor antagonists
Phillip M Cowley, James Baker, David R Barn, et al.
Journal of Medicinal Chemistry
|
October 19, 2001
Alpha-amino acid phenolic ester derivatives: novel water-soluble general anesthetic agents which allosterically modulate GABA(A) receptors
A Anderson, D Belelli, D J Bennett, et al.
Journal of Medicinal Chemistry
|
January 4, 2021
Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action Studies
Candice Soares de Melo, Vinayak Singh, Alissa Myrick, et al.
Journal of Medicinal Chemistry
|
August 1, 2025
Design and Development of Lysyl tRNA Synthetase Inhibitors, for the Treatment of Tuberculosis
Susan H Davis, Michael Mathieson, Kirsteen I Buchanan, et al.
Nature Communications
|
October 11, 2022
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
Simon R Green, Susan H Davis, Sebastian Damerow, et al.
ACS Infectious Diseases
|
October 6, 2016
Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis
Yumi Park, Angela Pacitto, Tracy Bayliss, et al.
Page
of 5